| Date Filed | Type | Description |
| 08/22/2023 |
4
| WYZGA MICHAEL S (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Bought 25,000 shares
@ $1.195, valued at
$29.9k
|
|
| 08/16/2023 |
3
| Arbet-Engels Christophe (Chief Medical Officer) has filed a Form 3 on X4 Pharmaceuticals, Inc |
| 08/11/2023 |
4
| Stewart Murray (Interim Chief Medical Officer) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 269,893 shares
@ $0
Sold 130,056 shares
@ $1.06, valued at
$137.9k
|
|
| 07/05/2023 |
4
| DiBiase Mary (COO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 464 shares
@ $1.89, valued at
$877 |
|
| 07/05/2023 |
4
| Mostafa Adam S. (CFO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 2,641 shares
@ $1.89, valued at
$5k
|
|
| 06/16/2023 |
4
| DiBiase Mary (COO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 857 shares
@ $2.23, valued at
$1.9k
|
|
| 06/16/2023 |
4
| Mostafa Adam S. (CFO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 5,417 shares
@ $2.22, valued at
$12k
|
|
| 06/16/2023 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 6,724 shares
@ $2.23, valued at
$15k
|
|
| 05/31/2023 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 6,292 shares
@ $1.95, valued at
$12.3k
|
|
| 03/13/2023 |
4
| DiBiase Mary (COO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 18,192 shares
@ $0.84, valued at
$15.3k
|
|
| 03/13/2023 |
4
| Mostafa Adam S. (CFO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 52,500 shares
@ $0.84, valued at
$44.1k
|
|
| 03/13/2023 |
4
| Taveras Arthur (Chief Scientific Officer) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 16,806 shares
@ $0.84, valued at
$14.1k
|
|
| 03/13/2023 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 49,678 shares
@ $0.84, valued at
$41.7k
|
|
| 11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| DiBiase Mary (COO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 1,713 shares
@ $0 |
|
| 08/19/2022 |
4
| Ragan Paula (President and CEO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 13,448 shares
@ $0 |
|
| 08/19/2022 |
4
| Mostafa Adam S. (CFO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 10,834 shares
@ $0 |
|
| 07/01/2022 |
4
| Mostafa Adam S. (CFO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 2,641 shares
@ $0 |
|
| 07/01/2022 |
4
| DiBiase Mary (COO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 1,578 shares
@ $0 |
|
| 06/27/2022 |
4
| Bridger Gary (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 6,667 shares
@ $0 |
|
| 06/27/2022 |
4
| Lawton Alison Frances (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 6,667 shares
@ $0 |
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Stewart Murray (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 6,667 shares
@ $0 |
|
| 06/27/2022 |
4
| Aliski William (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 6,667 shares
@ $0 |
|
| 06/27/2022 |
4
| Mostafa Adam S. (CFO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 5,416 shares
@ $0 |
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| DiBiase Mary (COO) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Sold 856 shares
@ $0 |
|
|